Ahead of print
Original Article
Published online: 2022-11-07

open access

Page views 1076
Article views/downloads 358
Get Citation

Connect on Social Media

Connect on Social Media

The occurrence of cardiovascular risk factors and functioning in chronic illness in the Polish population of EUROASPIRE V

Aldona Kubica1, Łukasz Pietrzykowski1, Piotr Michalski1, Michał Kasprzak2, Jakub Ratajczak1, Joanna Siódmiak3, Tomasz Fabiszak2, Krzysztof Buczkowski4, Magdalena Krintus3, Piotr Jankowski56

Abstract

Background: The aim of this study was to assess the impact of cardiovascular risk on the functioning of patients without a history of atherosclerotic cardiovascular disease. Methods: Two hundred patients diagnosed with arterial hypertension, hypercholesterolemia, or diabetes were enrolled in the study. The median age was 52.0 years (interquartile range [IQR] 43.0–60.0). The following risk factors were assessed: blood pressure, body mass index, waist circumference, physical activity, smoking, LDL-cholesterol, triglycerides, and fasting plasma glucose concentration. Total cardiovascular risk was determined as the number of uncontrolled risk factors, and with the Systemic Coronary Risk Evaluation Score (SCORE). The Functioning in the Chronic Illness Scale (FCIS) was applied to assess the physical and mental functioning of patients. Results: The median number of measures of cardiovascular risk factors was 4.0 (IQR 3.0–5.0). The median of SCORE for the whole study population was 2.0 (IQR 1.0–3.0). Patients with lower total cardiovascular risk as defined by SCORE and number of uncontrolled risk factors had better functioning as reflected by higher FCIS (R = –0.315, p < 0.0001; R = –0.336, p < 0.0001, respectively). Multivariate logistic regression analysis identified abnormal blood pressure, abnormal waist circumference, tobacco smoking, and lack of regular physical activity to be negative predictors of functioning. Lack of regular physical activity was the only predictor of low FCIS total score (odds ratio 9.26, 95% confidence interval 1.19–71.77, p = 0.03). Conclusions: The functioning of patients worsens as the total cardiovascular risk increases. Each of the risk factors affects the functioning of subjects without coronary artery disease with different strength, with physical activity being the strongest determinant of patient functioning.

Article available in PDF format

View PDF Download PDF file

References

  1. Kotseva K, De Backer G, De Bacquer D, et al. Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries. Eur J Prev Cardiol. 2021; 28(4): 370–379.
  2. SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021; 42(25): 2439–2454.
  3. Conroy R. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003; 24(11): 987–1003.
  4. Uchmanowicz I, Lisiak M, Wleklik M, et al. The relationship between frailty syndrome and quality of life in older patients following acute coronary syndrome. Clin Interv Aging. 2019; 14: 805–816.
  5. Lourenço E, Sampaio MR, Nzwalo H, et al. Determinants of quality of life after stroke in Southern Portugal: a cross sectional community-based study. Brain Sci. 2021; 11(11): 1509.
  6. Galiè N, Humbert M, Vachiery JL, et al. ESC Scientific Document Group. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016; 37(1): 67–119.
  7. Zdrojewski T, Jankowski P, Bandosz P, et al. [A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population]. Kardiol Pol. 2015; 73(10): 958–961.
  8. Tomasik T, Krzysztoń J, Dubas-Jakóbczyk K, et al. The systematic coronary risk evaluation (SCORE) for the prevention of cardiovascular diseases. Does evidence exist for its effectiveness? A systematic review. Acta Cardiol. 2017; 72(4): 370–379.
  9. Mach F, Baigent C, Catapano A, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2019; 41(1): 111–188.
  10. Buszko K, Pietrzykowski Ł, Michalski P, et al. Validation of the Functioning in Chronic Illness Scale (FCIS). Med Res J. 2018; 3(2): 63–69.
  11. Kubica A. Self-reported questionnaires for a comprehensive assessment of patients after acute coronary syndrome. Med Res J. 2019; 4(2): 106–109.
  12. Kubica A, Bączkowska A. Rationale for motivational interventions as pivotal element of multilevel educational and motivational project MEDMOTION. Folia Cardiologica. 2020; 15(1): 6–10.
  13. Hawkes AL, Patrao TA, Ware R, et al. Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patients. BMC Cardiovasc Disord. 2013; 13: 69.
  14. Assari S, Moghani Lankarani M, Ahmadi K. Comorbidity influences multiple aspects of well-being of patients with ischemic heart disease. Int Cardiovasc Res J. 2013; 7(4): 118–123.
  15. Lalonde L, Clarke AE, Joseph L, et al. Health-related quality of life with coronary heart disease prevention and treatment. J Clin Epidemiol. 2001; 54(10): 1011–1018.
  16. Olano-Lizarraga M, Oroviogoicoechea C, Errasti-Ibarrondo B, et al. The personal experience of living with chronic heart failure: a qualitative meta-synthesis of the literature. J Clin Nurs. 2016; 25(17-18): 2413–2429.
  17. Røe C, Sveen U, Bautz-Holter E. Retaining the patient perspective in the international classification of functioning, disability and health core set for low back pain. Patient Prefer Adherence. 2008; 2: 337–347.
  18. Garin O, Ayuso-Mateos JL, Almansa J, et al. Validation of the "World Health Organization Disability Assessment Schedule, WHODAS-2" in patients with chronic diseases. Health Qual Life Outcomes. 2010; 8: 51.
  19. Bohn K, Doll HA, Cooper Z, et al. The measurement of impairment due to eating disorder psychopathology. Behav Res Ther. 2008; 46(10): 1105–1110.
  20. Bohn K. Clinical Impairment Assessment Questionnaire (CIA). Encyclopedia of Feeding and Eating Disorders. Springer, Singapore 2017: 126–129.
  21. Carson P, Tam SW, Ghali JK, et al. Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial. J Card Fail. 2009; 15(10): 835–842.
  22. Juenger J, Schellberg D, Kraemer S, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart. 2002; 87(3): 235–241.
  23. Kurpas D, Mroczek B, Knap-Czechowska H, et al. Quality of life and acceptance of illness among patients with chronic respiratory diseases. Respir Physiol Neurobiol. 2013; 187(1): 114–117.
  24. Jankowska-Polańska B, Kaczan A, Lomper K, et al. Symptoms, acceptance of illness and health-related quality of life in patients with atrial fibrillation. Eur J Cardiovasc Nurs. 2018; 17(3): 262–272.
  25. Lewko J, Polityńska B, Kochanowicz J, et al. Quality of life and its relationship to the degree of illness acceptance in patients with diabetes and peripheral diabetic neuropathy. Adv Med Sci. 2007; 52(Suppl 1): 144–146.
  26. Benetos A, Gautier S, Labat C, et al. Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study. J Am Coll Cardiol. 2012; 60(16): 1503–1511.
  27. Pedrosa H, De Sa A, Guerreiro M, et al. Functional evaluation distinguishes MCI patients from healthy elderly people: the ADCS/MCI/ADL scale. J Nutr Health Aging. 2010; 14(8): 703–709.
  28. Devlin NJ, Brooks R. EQ-5D and the EuroQol group: past, present and future. Appl Health Econ Health Policy. 2017; 15(2): 127–137.
  29. Oris L, Luyckx K, Rassart J, et al. Illness identity in adults with a chronic illness. J Clin Psychol Med Settings. 2018; 25(4): 429–440.
  30. Sengul Y, Kara B, Arda MN. The relationship between health locus of control and quality of life in patients with chronic low back pain. Turk Neurosurg. 2010; 20(2): 180–185.
  31. Wielenga-Boiten JE, Heijenbrok-Kal MH, Ribbers GM. The relationship of health locus of control and health-related quality of life in the chronic phase after traumatic brain injury. J Head Trauma Rehabil. 2015; 30(6): 424–431.
  32. Cramm JM, Strating MMH, Roebroeck ME, et al. The importance of general self-efficacy for the quality of life of adolescents with chronic conditions. Soc Indic Res. 2013; 113(1): 551–561.
  33. Maeda U, Shen BJ, Schwarz ER, et al. Self-efficacy mediates the associations of social support and depression with treatment adherence in heart failure patients. Int J Behav Med. 2013; 20(1): 88–96.
  34. Moljord IE, Lara-Cabrera ML, Perestelo-Pérez L, et al. Psychometric properties of the patient activation measure-13 among out-patients waiting for mental health treatment: A validation study in Norway. Patient Educ Couns. 2015; 98(11): 1410–1417.
  35. Michalski P, Kasprzak M, Kosobucka A, et al. Sociodemographic and clinical determinants of the functioning of patients with coronary artery disease. Med Res J. 2021; 6(1): 21–27.
  36. Kubica A, Michalski P, Kasprzak M, et al. Functioning of patients with post-COVID syndrome — preliminary data. Med Res J. 2021; 6(3): 224–229.
  37. Kubica A, Adamski P, Bączkowska A, et al. The rationale for Multilevel Educational and Motivational Intervention in Patients after Myocardial Infarction (MEDMOTION) project is to support multicentre randomized clinical trial Evaluating Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome (ELECTRA – SIRIO 2). Med Res J. 2020; 5(4): 244–249.
  38. Kubica J, Adamski P, Gorog DA, et al. Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial. Cardiol J. 2022; 29(1): 148–153.
  39. Spinka F, Aichinger J, Wallner E, et al. Functional status and life satisfaction of patients with stable angina pectoris in Austria. BMJ Open. 2019; 9(9): e029661.
  40. Pattyn N, Vanhees L, Cornelissen VA, et al. The long-term effects of a randomized trial comparing aerobic interval versus continuous training in coronary artery disease patients: 1-year data from the SAINTEX-CAD study. Eur J Prev Cardiol. 2016; 23(11): 1154–1164.
  41. Reriani M, Flammer AJ, Duhé J, et al. Coronary endothelial function testing may improve long-term quality of life in subjects with microvascular coronary endothelial dysfunction. Open Heart. 2019; 6(1): e000870.
  42. Oreopoulos A, Padwal R, McAlister FA, et al. Association between obesity and health-related quality of life in patients with coronary artery disease. Int J Obes (Lond). 2010; 34(9): 1434–1441.